Filing Flows › RXO (RXO) › Stock forecast & fair value
RXO (RXO) stock forecast and fair value
RXO (RXO) trades at $27.61. 13 analysts' median price target is $30.00 (+9%), from $28.00 to $33.00. Across 17 valuation methods the middle fair value is $22.05 (-20%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/EBITDA vs peers | $0.06 | $1.00 | $2.74 | -96% |
| EV/EBITDA vs peers, weighted | $0.57 | $1.70 | $2.75 | -94% |
| EV/Sales vs peers | $81.17 | $136.19 | $290.58 | +393% |
| EV/Sales vs peers, weighted | $36.03 | $88.86 | $213.71 | +222% |
| Residual income | $3.76 | $3.89 | $4.03 | -86% |
| Analysts' price targets | $28.00 | $29.83 | $33.00 | +8% |
| Path-to-margin DCF | $5.45 | $19.59 | $33.73 | -29% |
| Path-to-margin DCF, dilution-adjusted | $5.45 | $19.59 | $33.73 | -29% |
| Exit-multiple (venture) method | $24.97 | $37.81 | $69.35 | +37% |
| EV/Sales vs Rule of 40 (all-company fit) | $24.29 | $71.41 | $200.66 | +159% |
RXO's latest quarter
RXO, Q3 2026: revenue $1.9B (+32% year over year), operating margin 0.9%, net earnings $3.0M, operating cash flow $25.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for RXO stock?
The median of 13 analysts' 12-month targets is $30.00, +9% from $27.61; the range is $28.00 to $33.00. The average rating is hold.
What is RXO's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.28 and $136.19, with a middle value of $22.05 against a price of $27.61. Each method's assumptions are on the page.
Does RXO usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is RXO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.